Integrating imaging and omics for enhanced subtyping of mild cognitive impairment associated with Alzheimer's disease.

Summary: Mild Cognitive Impairment (MCI) is an early stage of memory loss that can sometimes lead to Alzheimer's disease. But not everyone with MCI gets worse at the same speed. Some people stay stable for a long time, while others quickly develop Alzheimer's. In this study, scientists combined brain scans, spinal fluid tests, and memory scores to group patients. They discovered two main types of MCI: a "resilient" group with healthier brains that stayed stable, and a "vulnerable" group with more brain shrinkage that quickly worsened. By understanding these two distinct groups, doctors can better predict who will get Alzheimer's and find specific, targeted drugs to help each type of patient.